Navigation Links
OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials
Date:12/6/2007

enes that produce vascular endothelial growth factor (VEGF), believed to be largely responsible for the vision loss of wet AMD. Bevasiranib is the first therapy based on the Nobel Prize-winning RNA interference (RNAi) technology to advance to Phase III clinical trials.

The multi-national Phase III COBALT (Combining Bevasiranib And Lucentis Therapy) clinical trial of bevasiranib for the treatment of wet AMD is currently enrolling patients at multiple clinical sites. For more information about the COBALT trial, please visit http://www.opko.com/clinicaltrials

About OPKO Health, Inc.

Miami-based OPKO is a specialty healthcare company. Its lead investigational drug, the pioneering gene silencing agent bevasiranib, has entered a pivotal Phase III trial after successfully completing Phase II trials for wet age-related macular degeneration and diabetic macular edema. OPKO is developing a preclinical pipeline of novel agents for ophthalmic diseases, and it markets innovative diagnostic imaging systems that complement the company's therapeutic products. For more information visit the company's website at http://www.opko.com.

This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning, including statements regarding bevasiranib's potential ability to achieve similar results as current therapies while requiring less frequent injections, statement's about bevasiranib's safety profile, which might not be as important to patients as anticipated, statements about our product development efforts, and our ability to develop a preclinical pipeline of novel agents for o
'/>"/>

SOURCE OPKO Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Keith Taft Named General Manager of UltraTape Industries
2. Summa Health Systems Akron City Hospital Named Leapfrog Top Hospital for 2007
3. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
4. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
5. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
6. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
7. New Director of Nursing Practice Named for Nurses Association
8. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
9. Meeting Expectations Named to First Annual CMI 25 List by Corporate Meetings & Incentives Magazine
10. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
11. AIUM CEO named among most influential in radiology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Passages Malibu, the leading non-12 step, ... this week the launch of a “Sobriety, Health, and ... channels. “We are always looking for new ways ... get feedback regarding sobriety, what’s working for people, and ... the Passages Addiction Treatment Centers located in ...
(Date:5/19/2013)... May 19, 2013 The AMTC team will ... the Columbus Georgia Convention & Trade Center on June 1st. ... attend. AMTC auditions are free of charge. , Actors, Models ... for hundreds of successful artists and grads like Caitlin Kinney ... European Tombolini , Chris Young - on his Liquid Neon ...
(Date:5/19/2013)... The legal team at Pulaski & Middleman, ... effort to connect women and families coping with the ... Yasmin & Ocella with the legal representation they need. ... notorious birth control drugs as well as news and ... Yasmin & Ocella were very popular birth control medications ...
(Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
(Date:5/18/2013)... Each year, the American Gastroenterological Association (AGA) ... achievements in gastroenterology through its esteemed recognition awards. ... talented individuals who work tirelessly to advance the ... pleased to announce the 2013 recognition award honorees ... their tremendous contributions to our field," said Loren ...
Breaking Medicine News(10 mins):Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5
... in to Boston from India, on April 26, brought over ... the 18th floor of the John Hancock Tower, little did ... ,On May 5 the characteristic symptoms of measles ... measles struck another half-dozen workers at Investors Bank & Trust, ...
... at new prescription- only medicines that were publicly funded between 2000 ... new prescription-only medicines have been listed on the Australian PBS, ... are registered in New Zealand, of which only 20 are ... New Zealand is slower to fund new drugs when compared ...
... the Queensland Department of Primary Industries (DPI) has quarantined ... ,Although the DPI has not yet confirmed what ... could be serious.,The general manager of plant biosecurity, Chris ... trace-back and trace-forward process and would also begin surveillance ...
... has provided $7 million towards development of some of ... //. ,According to the incoming president of ... beds and acute care beds would help to provide ... opinions differ, with Dr. Margaret MacDiarmid hoping that new ...
... According to the doctors at Kozhikode Medical College Hospital, Kerala ... //. ,The man named Akkooppoyil Achuthan aged 65 ... six Kg tumor. ,Then he was discharged but ... an X-ray another doctor found the scissors in the stomach. ...
... of the gene responsible for Type 2 diabetes scientists have ... //. ,The PSARL gene associated with the Type ... in Washington tomorrow. ,Diabetes, now considered as an ... about $3 billion annually. ,Diabetes has long been ...
Cached Medicine News:Health News:Global Threat of Measles Outbreak 2
(Date:5/16/2013)... 2013  Nektar Therapeutics, (Nasdaq: NKTR ) President ... , is scheduled to present at the upcoming 2013 UBS ... at the Sheraton New York Hotel on Tuesday, May 21, ... will be accessible via a Webcast through a link posted ... website: http://www.nektar.com . This Webcast will be available for ...
(Date:5/16/2013)... Mass. , May 16, 2013  Alere Inc. (NYSE: ... to take charge of their health at home through the ... cash dividend of $3.00 per share on its Series B ... on July 15, 2013 to holders of record of Series ... 2013.  Such payment will cover the amount of ...
(Date:5/16/2013)... , May 16, 2013 OrthoView ... the U.S. to access the widely-used OrthoView digital templating ... and Internet connection to get started. OrthoView, ... for over 10 years, is dedicated to enabling orthopaedic ... digital x-ray images, when printed film is unavailable. Over ...
Breaking Medicine Technology:Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
... Nile Therapeutics,Inc. (Nasdaq: NLTX ), today announced ... placebo-controlled clinical study of CD-NP, a novel,chimeric natriuretic ... heart failure., The primary objective of the ... physiologic parameters of intravenous infusions of,CD-NP in patients ...
... Transplant Monitoring Test that Meets International Standards for ... ... The ability of blood,tests to precisely measure very low doses ... difference in assuring long-term,viability and survival, according to research presented ...
Cached Medicine Technology:Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients 2Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients 3Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success 2Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success 3
... Stabilizer Plastazote® with plastic anterior ... straps. Chin cradle reduces rotation. ... be interchanged for individualized fitting.,Philadelphia™ ... standard Philadelphia Collar for added ...
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
Optical Mini Urethrotome for telescope 3.3 mm, 0...
... cystoscope is being used more and more as ... outstanding optical quality and large working/irrigation channel, the ... therapy. The outstanding flexibility of the cystoscope guarantees ... Being simple ...
Medicine Products: